Greenblum & Bernstein, P.L.C.
Method of treating cancer with an RPN2 gene expression inhibitor
The present invention uses an RPN2 gene expression inhibitor as a cancer cell growth inhibitor, which further includes a drug showing an anti-cancer action if desired, and is administered in combination with atelocollagen if desired. In addition, the present invention is an anti-cancer agent including such cancer cell growth inhibitor.
Taisho Pharmaceutical Co., Ltd. Japan as represented by President of National Cancer Center Koken Co., Ltd. Dainippon Sumitomo Pharma Co., Ltd.
C A C A A A A A A A
C12N A61P C12N A61K A61K A61P A61K A61P A61P A61K
additional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Takahiro Kikuya Kimi Yasuji
Ochiya Kato Honma Ueda